Bücher Wenner
Pierre Jarawan liest aus DIE FRAU IM MOND
03.09.2025 um 19:30 Uhr
Biotechnology: Potentials and Limitations
Report of the Dahlem Workshop on Biotechnology: Potentials and Limitations Berlin 1985, March 24-29
von S. Silver
Verlag: Springer Berlin Heidelberg
Reihe: Dahlem Workshop Report Nr. 35
Reihe: Life Sciences Research Report
E-Book / PDF
Kopierschutz: PDF mit Wasserzeichen

Hinweis: Nach dem Checkout (Kasse) wird direkt ein Link zum Download bereitgestellt. Der Link kann dann auf PC, Smartphone oder E-Book-Reader ausgeführt werden.
E-Books können per PayPal bezahlt werden. Wenn Sie E-Books per Rechnung bezahlen möchten, kontaktieren Sie uns bitte.

ISBN: 978-3-642-70535-9
Auflage: 1986
Erschienen am 06.12.2012
Sprache: Englisch
Umfang: 312 Seiten

Preis: 96,29 €

96,29 €
merken
Inhaltsverzeichnis
Klappentext

Technical Approaches: Group Report.- Cloning and Expressing Genes for Clinically Useful Proteins.- Synthetic Genes.- Protein Engineering.- Microbiology and Industrial Products: Group Report.- Fermentation Products: Physiological and Bioenergetic Considerations.- Bioactive Microbial Secondary Metabolites.- Technological Processes for Biotechnological Utilization of Microorganisms.- Animals and Medicines: Group Report.- Vaccines - The Synthetic Antigen Approach.- A Modern Approach to Live Vaccines: Recombinant Poxviruses.- The Future Role in Medicine of Proteins Made by Genetic Engineering.- Some Applications of Modern Immunological Techniques.- Gene Transfer into Mouse Stem Cells.- Plants and Agriculture: Group Report.- Plant Gene Engineering and Plant Agriculture.- Secondary Products.- Plant-Microbe Interactions.- Importance of the Rhizosphere in Plant-Microbe Interactions.- The Production and Utilization of Lignocellulose.- Social and Ethical Considerations for Biotechnology.- List of Participants with Fields of Research.- Author Index.



hurdle will be in the latter area. The technological hurdles will be formi­ dable but will not limit what happens: once the basic ideas are available, the technology will be developed. The unique part of biotechnology will be to imagine what the possibilities are. There was a discussion in several of the groups on the problems of intro­ ducing a novel science into a social and economic context. What biotech­ nologists are learning on this matter is not novel, although that does not make it any less important or difficult. People in the development of elec­ tronics and computers, in the pharmaceutical industry, and in many other types of industry that have grown from university research have had to face these problems in the past. It is the old situation of having to reinvent the wheel again and again. There is one aspect on which biotechnology seems to have handled this inherent difficulty better than some of our predecessor technologies: the people in the biotechnology companies by and large take a rather academic approach to free communication with one another at meetings such as this and open publication of many of their basic findings in the literature. This seems unique and certainly is different from the experience of the recent Silicone Valley Industry, which in other ways tries to emulate an academic environment, but not in open and free publication.


weitere Titel der Reihe